Weight Loss Drugs May Aid Alcohol Dependence

Weight loss medications like Wegovy and Mounjaro, known as GLP-1s, are showing potential in reducing alcohol dependency, according to recent studies. These drugs, which mimic hormones to regulate blood sugar and appetite, have been linked to a decrease in alcohol-related hospital admissions.

Analysis of over 40,000 individuals indicated that GLP-1 users experienced a 26% lower risk of alcohol-related hospital admission compared to those on other diabetes medicines. For weight loss patients, the risk decreased by 32% against other obesity drugs. Specific subgroups, like type 2 diabetics with alcohol issues and obese individuals with alcohol problems, saw even more substantial reductions.

While these findings, published in BMJ Open, suggest a possible role for GLP-1s in treating alcohol use disorder, researchers caution that the evidence is still developing. Experts note that these observational studies, primarily from the US, require more investigation to account for socioeconomic factors and confirm the findings definitively. The high cost of these newer GLP-1 treatments also means accessibility might differ.